Latest Breaking News On - தடுப்பூசி கூட்டமைப்பு - Page 3 : comparemela.com

Hester Biosciences to produce Bharat Biotech s Covaxin The MoU stated that Hester will provide complete infrastructure to manufacture the indigenously developed anti-COVID vaccine BusinessToday.In | May 28, 2021 | Updated 12:06 IST Ahmedabad-based Hester Biosciences will produce 20 million doses of Bharat Biotech s COVID-19 vaccine Covaxin per month from August 2021. A memorandum of understanding (MoU) has been inked between the Hyderabad-based pharma giant Bharat Biotech and Gujarat COVID Vaccine Consortium (GCVC) regarding the same. GCVC comprises Gujarat Biotechnology Research Centre (GBRC), Hester Biosciences and Omnibrx Biotechnologies, Hester stated in a regulatory filing. Bharat Biotech will provide production technology of the drug substance for Covaxin and GBRC will act as an advisor, mentor, and shall facilitate technology transfer from Bharat Biotech, as per this MoU. The MoU added Hester will provide complete infrastructure to manufacture the indigenously develope

Andhra pradeshRajiv gandhiHester biosciencesVaccine consortiumVekaria healthcareGujarat biotechnology research centreDepartment of biotechnologyAhmedabad based hester biosciencesBharat biotechOmnibrx biotechnologiesManaging director rajiv gandhiSupratech laboratoriesBharat biotech covid 19 vaccineBharat biotech covid 19 vaccine productionCovaxin productionBharat biotech covid 19 vaccine production facility